Israel Englander Acer Therapeutics Inc. Transaction History

Millennium Management LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$2.3 - $2.86 $26,337 - $32,749	-11,451 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$2.52 - $3.18 $28,856 - $36,414	11,451 New	11,451 $33,000
Q4 2019 Feb 14, 2020	SELL	$2.85 - $4.2 $43,616 - $64,276	-15,304 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$1.95 - $3.93 $29,842 - $60,144	15,304 New	15,304 $48,000
Q2 2019 Aug 14, 2019	SELL	$3.45 - $26.86 $206,627 - $1.61 Million	-59,892 Closed	0 $0
Q1 2019 May 14, 2019	BUY	$20.4 - $25.15 $1.22 Million - $1.51 Million	59,892 New	59,892 $1.46 Million

365

Ticker ACER
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 16,100,000
Description
Acer Therapeutics Inc., a pharmaceutical company, focuses on the acquisition, development, and commercialization of therapies for serious rare and life-threatening diseases. Its pipeline includes four clinical-stage candidates comprising EDSIVO for the treatment of vascular Ehlers-Danlos Syndrome in patients with a confirmed type III collagen mu...

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.